Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
Authors
Keywords
-
Journal
Immunotherapy
Volume 12, Issue 5, Pages 269-273
Publisher
Future Medicine Ltd
Online
2020-03-26
DOI
10.2217/imt-2020-0067
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunological insights on influenza infection and vaccination during immune checkpoint blockade in cancer patients
- (2020) Melissa Bersanelli et al. Immunotherapy
- Presumed Asymptomatic Carrier Transmission of COVID-19
- (2020) Yan Bai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
- (2020) Hussin A. Rothan et al. JOURNAL OF AUTOIMMUNITY
- Clinical trial analysis of 2019‐nCoV therapy registered in China
- (2020) Qi Zhang et al. JOURNAL OF MEDICAL VIROLOGY
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- (2020) Wenhua Liang et al. LANCET ONCOLOGY
- A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment
- (2020) Vincent J. Munster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Immune Checkpoint Inhibitor Therapy–related Pneumonitis: Patterns and Management
- (2019) Kevin R. Kalisz et al. RADIOGRAPHICS
- A systematic review on the emerging association between the occurrence of immune-related adverse events and clinical outcomes with checkpoint inhibitors in advanced cancer patients
- (2019) Alessio Cortellini et al. SEMINARS IN ONCOLOGY
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
- (2018) Daniel Y. Wang et al. JAMA Oncology
- INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study
- (2018) Melissa Bersanelli et al. Immunotherapy
- A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy
- (2018) Alice Horisberger et al. Journal for ImmunoTherapy of Cancer
- Severe cytokine release syndrome in a patient receiving PD-1-directed therapy
- (2017) Seth J. Rotz et al. PEDIATRIC BLOOD & CANCER
- Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade
- (2017) Chipman RG Stroud et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology
- (2013) Sarah N. Lauder et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now